Biogen partner NeuroSense seeks a role in the ALS revolution
PharmaVoice,
Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback.
Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback.
Dive Brief: Apellis Pharmaceuticals on Thursday became the latest drugmaker to give up on a potential treatment for amyotrophic…
Dive Brief: The Food and Drug Administration and National Institutes of Health launched a public-private initiative focused on…
Dive Brief: Brainstorm Cell Therapeutics now has a tougher decision to make regarding its experimental treatment for ALS…